谷丙转氨酶持续正常的慢性乙型肝炎病毒感染者肝脏病理特征及预测因素

doi:10.19871/j.cnki.xfcrbzz.2023.01.009

新发传染病电子杂志 ›› 2023, Vol. 8 ›› Issue (1): 44-47.doi: 10.19871/j.cnki.xfcrbzz.2023.01.009

谷丙转氨酶持续正常的慢性乙型肝炎病毒感染者肝脏病理特征及预测因素

李延东¹, 范荣山²

1.深圳市中西医结合医院病理科,广东深圳 518024;
2.深圳市中西医结合医院肝病科,广东深圳 518024

收稿日期:2022-08-22 出版日期:2023-02-28 发布日期:2023-03-30
通讯作者: 范荣山,Email：fanrongshan2010@163.com

Analysis of indications for antiviral therapy in chronic HBV patients with persistent normal level of alanine aminotransferase

Li Yandong¹, Fan Rongshan²

1. Pathology Department of Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine,0Guangdong Shenzhen 518104, China;
2. Hepatic Department of Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine,Guangdong Shenzhen 518104,China

Received:2022-08-22 Online:2023-02-28 Published:2023-03-30

摘要/Abstract

摘要： 目的观察谷丙转氨酶（ALT）水平持续正常的慢性乙型肝炎病毒（HBV）感染者的肝脏病理特征,分析影响肝脏炎症和肝纤维化的危险因素,明确抗病毒治疗的准确时机。方法回顾性分析2020年9月至2022年1月于深圳市中西医结合医院住院的150例血清ALT水平持续低于正常值上限（ULN）的慢性HBV感染者的临床资料,对所有研究对象的肝脏病理结果和实验室检测结果进行统计分析,采用单因素分析和多因素回归分析影响患者发生明显肝脏炎症（G≥2）或纤维化（S≥2）的危险因素。结果 93例（62.0%）患者的肝组织 G≥2级或S≥2级。单因素分析显示,ALT>25U/L、谷氨酰转肽酶（GGT）>20U/L、前白蛋白（PA）≤230g/L、血小板（PLT）计数≤160×10⁹/L、部分活化凝血酶原时间（APTT）>28s是ALT水平持续正常的慢性HBV感染者肝脏病理发生G≥2或S≥2的危险因素（P<0.05）;二分类逻辑回归的多因素分析显示,ALT>25U/L、PLT计数≤160×10⁹/L、APTT>28s是ALT水平持续正常的慢性HBV感染者肝脏病理发生G≥2或S≥2的独立危险因素。结论对于ALT<ULN的慢性HBV感染者,ALT、PLT和APTT水平可作为预测肝脏组织发生明显病变的独立危险因素和抗病毒治疗的依据。

关键词: 慢性乙型肝炎, 肝脏病理, 谷丙转氨酶, 预测因素

Abstract: Objective To investigate the feature of liver pathology in chronic HBV patients with normal level of alanine aminotransferase (ALT),to analyze the risk factors of liver inflammation and fibrosis ,to determine the exact timing of antiviral treatment. Method The clinical data of 150 patients with chronic HBV infection with normal level of serum ALT in Shenzhen Hospital of Integrated Traditional And Western Medicine from September 2020 to January 2022 were retrospectively collected and the liver pathological results of all subjects were statistically analyzed. Univariate analysis and multivariate regression were used to analyze the risk factors for significant liver inflammation (G≥2) or fibrosis (S≥2). Result The pathological examination of liver tissue reveal G≥2 or S≥2 in 93 cases (62.00%). Univariate analysis showed that ALT>25U/L, glutamyl transpeptidase (GGT)>20U/L, prealbumin (PA)≤230g/L, platelet(PLT) count ≤160×10⁹/L, partial activated prothrombin time (APTT) >28s were the possible risk factors for liver pathology G≥2 or S≥2 in chronic HBV patients with normal level of ALT (P<0.05); Multivariate analysis of binary logistic regression showed that ALT>25U/L, PLT count≤160×10⁹/L and APTT>28s were independent risk factors for liver pathology G≥2 or S≥2 in chronic HBV patients with normal level of ALT. Conclusion ALT level, PLT level and APTT level can be used as the basis for judging the severity of liver pathology and receiving antiviral therapy in chronic HBV infected patients with normal level of ALT.

Key words: Chronic hepatitis B, Liver pathology, Alanine aminotransferase, Predictive factors

中图分类号:

李延东, 范荣山. 谷丙转氨酶持续正常的慢性乙型肝炎病毒感染者肝脏病理特征及预测因素[J]. 新发传染病电子杂志, 2023, 8(1): 44-47.

Li Yandong, Fan Rongshan. Analysis of indications for antiviral therapy in chronic HBV patients with persistent normal level of alanine aminotransferase[J]. Electronic Journal of Emerging Infectious Diseases, 2023, 8(1): 44-47.

参考文献

[1] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 中国医学前沿杂志(电子版), 2019, 11(12):51-77.
[2] 孙亚朦, 贾继东, 尤红. 2022年《扩大慢性乙型肝炎抗病毒治疗的专家意见》解读[J]. 中国临床医生杂志, 2022, 50(10):1144-1146.
[3] LURIE Y, WEBB M, CYTTER-KUINT R,et,al. Non-invasive diagnosis of liver fibrosis and cirrhosis[J]. World J Gastroenterol, 2015, 21(41):11567-11583.
[4] LIAW YF.Natural history of chronic hepatitis B virus infection and long-term outcome under treatment[J]. Liver Int,2009,29(Suppl 1) : 100-107.
[5] 中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年版)[J].中国肝脏病杂志(电子版), 2015, (3):1-18.
[6] CHU CM, LIAW YF.Prognosis of immune-tolerant phase chronic hepatitis B[J]. Gut, 2018, 67(5):988-989.
[7] 李强,黄玉仙,陈良.ALT正常的HBeAg阳性高病毒载量慢性HBV感染者明显肝组织学改变的独立预测因素[J].临床肝胆病杂志,2016,32(7):1210-1314.
[8] GUI HL, WANG H,YANG YH,et,al. Significant histopathlolgy in Chinese chronic hepatitis B patients with persistently high-normal alanine aminotransferase[J]. J Viral Hepat, 2010, 17(Suppl 1):44-50.
[9] DUAN M, CHI X, XIAO H, et al.High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B[J]. Hepatol Int, 2021, 15(2): 318-327.
[10] KIM GA, LIM YS, HAN S, et al.High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B[J]. Gut, 2018, 67(5):945-952.
[11] CHOI GH, KIM GA, CHOI JG, et al.High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no signifificant ALT elevation[J]. Aliment Pharmacol Ther, 2019, 50(2): 215-226.
[12] CHENG JL, WANG XL, YANG SG, et al.Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients[J]. World J Gastroenterol, 2017, 23(15):2802-2810.
[13] 胡梦琳,潘爱萍,张雨,等.低水平谷丙转氨酶慢性HBV感染者135例肝脏病理特征及影响因素分析[J].中华临床感染病杂志,2020, 13(1):55-60.
[14] 李晓月,李述捷,易永祥. 乙型肝炎病毒和丙型肝炎病毒相关性肝癌的研究进展[J/CD].新发传染病电子杂志, 2022, 7(1):92-99.

谷丙转氨酶持续正常的慢性乙型肝炎病毒感染者肝脏病理特征及预测因素

Analysis of indications for antiviral therapy in chronic HBV patients with persistent normal level of alanine aminotransferase

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

本文评价

[1]	王宏霞, 王艳, 段瑞娴, 张建伟, 任圆. 代谢综合征及其组分对慢性乙型肝炎患者血清HBsAg水平的影响[J]. 新发传染病电子杂志, 2023, 8(1): 31-34.
[2]	杨智, 吴伟刚, 欧鹏程, 李斌, 杨桂林. 成人EBV感染临床特点及发生噬血细胞综合征的预测因素[J]. 新发传染病电子杂志, 2022, 7(2): 35-40.
[3]	丁霞, 廖桂婵, 夏牧晔, 彭劼. 探讨长期核苷（酸）类药物治疗慢性乙型肝炎患者停药后复发的影响因素[J]. 新发传染病电子杂志, 2019, 4(1): 52-57.
[4]	蓝云翠, 刘曦, 丁立, 周耀勇, 夏瑾瑜. 611例CHB患者的临床指标与肝脏组织学关系研究[J]. 新发传染病电子杂志, 2017, 2(2): 72-75.